Hem › Esophageal adenocarcinom › Massachusetts › Boston
Kliniska studier för Esophageal adenocarcinom i Boston, MA
13 studier för Esophageal adenocarcinom söker deltagare vid platser i och runt Boston (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
RekryterarFas 1
- Dana-Farber Cancer Institute, Boston
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
RekryterarFas 3
- Boston Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RekryterarFas 1
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
RekryterarFas 1/2
- Dana-Farber Cancer Institute, Boston
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas
RekryterarFas 2
- Massachusetts General Hospital, Boston
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Rekryterar
- Beth Israel Deaconess Medical Center, Boston
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RekryterarFas 3
- Research Site, Boston
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekryterarFas 1
- Normunity Investigational Site, Boston
- Normunity Investigational Site, Boston
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekryterarFas 1
- Massachusetts General Hospital, Boston
- Brigham & Women's Hospital, Boston
- Beth Israel Deaconess Medical Center,East Campus Research Pharmacy, Boston
- och 2 fler
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
RekryterarObservationsstudie
- Dana-Farber Cancer Institute, Boston
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
RekryterarFas 1
- Research Site, Boston
Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
RekryterarFas 2
- I-Mab Site 1002, Boston
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
RekryterarFas 1
- Mass General Hospital, Boston
Esophageal adenocarcinom-studier i andra städer
- New York City, NY18 studier
- Houston, TX12 studier
- Nashville, TN11 studier
- Arlington, VA11 studier
- Durham, NC10 studier
- Rochester, MN9 studier
- Baldwin Park, CA9 studier
- St. Louis, MO9 studier
- Jacksonville, FL9 studier
- Queens, NY9 studier
- Los Angeles, CA9 studier
- Philadelphia, PA8 studier
Andra studier i Boston
- Bröstcancer112 studier
- Icke-småcellig lungcancer90 studier
- Cancer (alla typer)85 studier
- Metastaserande cancer63 studier
- Kolorektal cancer63 studier
- Lungcancer62 studier
- Äggstockscancer61 studier
- Prostatacancer59 studier
- Depression52 studier
- Endometriecancer50 studier
- Hjärtsvikt44 studier
- Akut myeloid leukemi44 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.